U.S. Metals and Mining Stock News

GeneDx Holdings (WGS) is back in focus after Ark Invest’s ETFs bought shares for seven straight trading days, alongside a new Niemann Pick disease type C genetic testing collaboration with Zevra Therapeutics. See our latest analysis for GeneDx Holdings. Despite Ark’s buying streak and the new Zevra partnership, GeneDx’s share price has been under pressure, with a 30 day share price return of a 16.25% decline and a year to date share price return of a 42.93% decline, while the three year total...

Recent performance snapshot EyePoint (EYPT) has drawn attention after mixed recent returns, with the share price up about 7% over the past month but showing a decline over the past 3 months and year to date. At a last close of US$13.90 and a market value of about US$1.12b, investors are weighing this performance against the company’s focus on retinal disease treatments and its developing product pipeline. See our latest analysis for EyePoint. That mix of a 7.42% 30 day share price return...

Madison Square Garden Entertainment (MSGE) has drawn fresh investor attention after appointing Allen Lo as Executive Vice President and Chief Legal Officer, a move that more closely connects the live entertainment group to deep technology and media legal expertise. See our latest analysis for Madison Square Garden Entertainment. The appointment of Allen Lo comes at a time when MSGE’s share price has pulled back in the short term. The 1 month share price return shows an 8% decline, but the 90...

In March 2026, Corvus Pharmaceuticals filed a universal shelf registration and expanded its at-the-market equity program with Jefferies to US$200 million, adding flexibility to issue common and preferred stock, debt, warrants and units to support ongoing operations. This expanded financing capacity sits alongside a sharp reduction in full-year 2025 net loss to US$15.28 million and continued clinical progress for lead candidate soquelitinib, together reshaping how investors may view the...

Recent performance snapshot Without a single clear news headline driving the move, Excelerate Energy (EE) has still drawn attention after a mixed run, with a roughly 17% decline over the past month alongside a gain of about 32% in the past 3 months. See our latest analysis for Excelerate Energy. At a share price of $34.65, Excelerate Energy’s recent 17% one-month share price decline contrasts with its 31.8% three-month share price return and 75% three-year total shareholder return, suggesting...

In March 2026, BlackLine, Inc. expanded its stock repurchase authorization to a total of US$500 million and, under a cooperation agreement with activist investor Engaged Capital, added AI-focused M&A adviser Storm Duncan and technology executive Megan Prichard to its board and key committees. The combination of a larger buyback program and governance changes linked to Engaged Capital signals a sharpened focus on capital allocation, board oversight, and potential strategic options for the...

Wondering if Trip.com Group is starting to look like value or a value trap at around US$52 a share? This article breaks down what the current price might be implying. The stock is around US$52.41, with a 1 week return of a 1.4% decline, a 30 day return of a 3.7% decline, and a year to date return of a 29.6% decline, alongside a 1 year return of a 20.7% decline and gains of 38.2% and 32.5% over 3 and 5 years respectively. Recent coverage of Trip.com Group has focused on how the share price...

Parsons (PSN) has attracted attention after recent share price swings, with the stock up about 3% over the past day but showing declines over the past week, month and past 3 months. See our latest analysis for Parsons. That 3% one day share price gain comes after a weaker patch, with the 30 day share price return of 14.52% and year to date share price return of 12.91% both in negative territory, even as the 3 year total shareholder return of 29.74% shows a stronger longer term picture. If...

Tencent Music Entertainment Group (NYSE:TME) just put fresh numbers on the board for FY 2025, with third quarter revenue of C¥8.5b and basic EPS of C¥1.40, set against the backdrop of trailing twelve month revenue of C¥31.7b and EPS of C¥7.05. Over recent quarters, revenue has moved from C¥7.0b in Q3 2024 to C¥7.5b in Q4 2024, C¥7.4b in Q1 2025, C¥8.4b in Q2 2025 and now C¥8.5b in Q3 2025. Quarterly EPS tracked from C¥1.02 to C¥1.27, C¥2.81, C¥1.57 and C¥1.40 over the same stretch. For...

D.R. Horton recently reported quarterly earnings that exceeded analyst expectations even as revenue fell, reflecting affordability pressures and high interest rates weighing on home sales, while also announcing plans for US$2.50 billion in share repurchases and US$500 million in dividends for fiscal 2026. At the same time, the company’s shrinking backlog, lower earnings per share, and weaker return on invested capital highlight mounting pressure on its ability to find profitable growth...

If you are wondering whether Healthpeak Properties is attractively priced or not, its current share price of US$17.65 only tells part of the story. The stock has returned 1.4% over the last week, 5.7% over the last month, and 9.0% year to date, while the 1 year return sits at a 7.6% decline and the 5 year return at a 27.1% decline. These mixed returns sit against a backdrop where Healthpeak Properties is part of the Health Care REITs space, a segment many investors watch for income and...

Granite Construction (GVA) is back in focus after Candelo Capital Management initiated a new position of 49,088 shares, following a record operational year and a large pipeline of committed and awarded projects. See our latest analysis for Granite Construction. Granite Construction's share price has eased in the short term, with a 1 day share price return of a 1.15% decline and a 30 day share price return of a 7.09% decline. However, the 1 year total shareholder return of 67.32% and 3 year...

In the most recent quarter, MSC Industrial reported revenue growth of 4% year on year and exceeded analyst estimates for EBITDA and adjusted operating income. This earnings outperformance highlights how the company’s focus on execution and cost control can influence its financial resilience in a mixed demand backdrop. We’ll now examine how MSC Industrial’s stronger-than-expected earnings, especially the beat on EBITDA and adjusted operating income, affect its investment narrative. Explore...

On 5 March 2026, Waystar announced an expanded collaboration with Google Cloud to integrate Gemini models and data infrastructure more deeply into its AI-powered revenue cycle platform, aiming to scale automation across complex healthcare payment workflows. The next phase of this partnership focuses on agentic AI that combines financial and clinical intelligence from billions of transactions to reshape patient encounters and the full claims lifecycle. Next, we’ll examine how this deeper...

If you are wondering whether Procore Technologies at around US$59 a share is a bargain or just fairly priced, the valuation story is where things get interesting. The stock has recently shown mixed signals, with a 2.8% gain over the last 7 days and 12.7% over the last 30 days, while year to date it is down 15.8% and the 1 year return sits at a 14.0% decline. Recent attention on Procore has centered on its role in construction software and how investors are interpreting the stock's pullback...

Blackstone Mortgage Trust, Inc. has declared a US$0.47 per‑share first‑quarter 2026 dividend on its Class A common stock, payable April 15, 2026 to shareholders of record on March 31, 2026. Separately, investment manager Bamco Inc. NY increased its stake to about 1.01% in the third quarter of 2026, underscoring growing institutional engagement with Blackstone Mortgage Trust’s commercial real estate lending platform. Next, we’ll examine how Bamco Inc. NY’s larger position could shape...

If you are wondering whether Sarepta Therapeutics at US$16.84 is starting to look mispriced, you are not alone, the stock’s valuation picture is more nuanced than the headline share price suggests. The share price has fallen 4.6% over the last week, 5.3% over the last month, 21.0% year to date, and 77.1% over the last year, which has sharply changed how many investors may view the balance between risk and potential reward. These moves sit against a backdrop of ongoing attention on Sarepta’s...

The Walt Disney Company has recently overhauled its leadership, with Josh D’Amaro succeeding Bob Iger as CEO and Dana Walden taking charge of a newly unified Disney Entertainment structure that brings together streaming, film, television, games, and digital operations. This consolidation of creative and distribution oversight, alongside fresh leadership across parks, experiences, and communications, could materially influence how Disney coordinates content, monetizes its intellectual...

Freshpet has permanently revised its dog food advertising to remove or clarify "human grade" claims following a review by the National Advertising Division. The changes come after a recent regulatory challenge that focused on how clearly the company described the quality standards of its pet food. The updated claims reflect Freshpet's decision to align its marketing more closely with industry advertising guidelines. For investors watching NasdaqGM:FRPT, the move comes at a time when the...

Exact Sciences stock snapshot Exact Sciences (EXAS) has drawn investor attention after recent share price moves, with the stock near US$103.94 and return figures over the past year and past 3 years standing out against its 5 year record. See our latest analysis for Exact Sciences. The recent move in Exact Sciences' share price to around US$103.94 comes after a strong 1 year total shareholder return of 131.39%. However, the 5 year total shareholder return shows a decline of 21.26%, indicating...

Earlier in March 2026, SCAYLE announced it had been selected to power Levi Strauss & Co.’s global levi.com e-commerce platform across North America and Europe, with migrations scheduled to run through 2027 as Levi’s deepens its direct-to-consumer focus and expands its use of AI tools in stores and online. This move, alongside the completed sale of the Dockers brand and reinvestment in core labels, signals Levi’s intent to own more of its digital future while concentrating resources on...

If you are wondering whether Rayonier's current share price reflects its real worth, you are not alone. Many investors are asking if the stock now offers better value or just new risks. The share price closed at US$20.37, with returns of a 1.9% decline over 7 days, a 13.7% decline over 30 days and a 5.7% decline year to date, while the 1 year, 3 year and 5 year returns stand at a 19.3% decline, a 19.8% decline and an 11.2% decline respectively. These moves have come as Rayonier continues to...

Invitation Homes Inc. recently declared a quarterly cash dividend of US$0.30 per share on its common stock, payable on or before April 17, 2026, to shareholders of record as of March 26, 2026, while also working through the impacts of a US$47.20 million Federal Trade Commission settlement over undisclosed renter fees. At the same time, the company faces operational questions around occupancy and lease pricing and growing policy scrutiny of institutional ownership in single-family housing,...

10x Genomics (NasdaqGS:TXG) joined PerturbAI, NVIDIA, and the Allen Institute to help build and analyze what is being described as the world's largest in vivo CRISPR atlas. The project uses 10x Genomics' technology to connect genetic perturbations with cellular responses at scale, supporting causal genomics research. The new dataset is expected to be used in therapeutic discovery and is drawing attention from researchers and investors. For investors watching NasdaqGS:TXG, this scientific...